This inventor holds 2 USPTO granted patents. Top assignees: Conjuchem Biotechnologies Inc., Conjuchem, Inc.. Active years: 2006-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2007
Title: Roger Léger: Innovator in Growth Hormone and Gastrointestinal Treatments
Introduction
Roger Léger is a notable inventor based in St-Lambert, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of peptide derivatives that have important applications in medicine. With a total of 2 patents, Léger's work focuses on enhancing the efficacy of growth hormone and gastrointestinal treatments.
Latest Patents
Léger's latest patents include innovative advancements in growth hormone releasing factors and glucagon-like peptide 2 (GLP-2) derivatives. The first patent pertains to long-lasting growth hormone releasing factor derivatives. This invention relates to growth hormone releasing factor (GRF) derivatives, specifically GRF peptide derivatives that possess an extended in vivo half-life. These derivatives are designed to promote the endogenous production or release of growth hormone in both humans and animals. The second patent involves long-lasting GLP-2 for the treatment of gastrointestinal diseases and disorders. This invention focuses on GLP-2 peptide derivatives that also have an extended in vivo half-life, aimed at treating or preventing gastrointestinal disorders such as inflammatory bowel disease and other related functions throughout the gastrointestinal tract.
Career Highlights
Throughout his career, Roger Léger has worked with various companies, including Conjuchem Biotechnologies Inc. and Conjuchem, Inc. His expertise in biotechnology has allowed him to contribute to significant advancements in the field, particularly in peptide research and development.
Collaborations
Léger has collaborated with notable professionals in the industry, including Dominique P Bridon and Nissab Boudjellab. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Roger Léger's contributions to biotechnology, particularly in the areas of growth hormone and gastrointestinal treatments, highlight his innovative spirit and dedication to improving medical therapies. His patents reflect a commitment to advancing healthcare solutions through scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile